abstract |
The present invention provides methods and compositions for determining whether a cancer is resistant to treatment with an anti-mitotic agent, including treatment with T-DM1. It is determined whether ABCC3 gene is amplified and / or overexpressed in cancer. [Selection] Figure 7 |